Monthly Prescribing Reference

Breo Ellipta

Fluticasone furoate, vilanterol 50/25mcg, 100/25mcg, 200/25mcg; per inh; dry pwd for oral inh. Fluticasone furoate is a synthetic trifluorinated corticosteroid with anti-inflammatory activity. The ...
Business Wire

Global BREO Ellipta Drugs Market to Witness Rapid Growth by 2031, Fueled by Growing Chronic Obstructive Pulmonary Disease (COPD) Drugs Market - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global BREO Ellipta Drugs Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering. The global BREO ellipta drugs market is driven ...
Healthline

Trelegy Ellipta Interactions: Alcohol, Medications, and Others

Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) is a prescription inhaler used to treat asthma or COPD in adults. This drug can interact with certain ...
Healthline

Trelegy Ellipta: How It’s Used for Treating COPD

Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) is a prescription drug used to treat COPD. With COPD, you have lung damage that worsens over time ...
Washington Examiner

FDA panel backs inhaler drug for lung disease

WASHINGTON (AP) — A panel of respiratory experts voted Wednesday in favor of approving an experimental inhaler drug from GlaxoSmithKline and Theravance for treating chronic lung disease. A majority of ...
Monthly Prescribing Reference

Breo Ellipta

Fluticasone furoate, vilanterol 100/25mcg, 200/25mcg; per inh; dry pwd for oral inh. Increased risk of asthma-related events (death, hospitalizations, intubations) with LABA monotherapy (without ICS).